AtaiBeckley: 'Hold'; Eli Lilly Acquisition For $2.8 Billion Adds To Its Neuroscience Pipeline

AtaiBeckley is being acquired by Eli Lilly at $6.75/share plus a $2.50 CVR—see the deal terms, milestone risks, and pipeline ...

AtaiBeckley Shares Surge as Eli Lilly Seals $3.8B Acquisition Deal

Eli Lilly and Co LLY on Thursday agreed to acquire AtaiBeckley Inc. ATAI in a deal that values the clinical-stage mental ...

Historic Step for Alzheimer's Care in Canada: CDA-AMC Recognizes Clinical Value of LEQEMBI® (lecanemab) and Recommends Public Coverage for Early Alzheimer's Dis…

Canada's Drug Agency recognizes the clinical value of LEQEMBI®in slowing Alzheimer's progression and helping keep patients in ...

U.S. House District 3 primary election voter's guide: Meet the candidates

Democrat Anna Golladay and Republican incumbent Chuck Fleischmann do not face primary challengers. Here's what they had to say.
The Manila Times

DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update

DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT - CUSIP: 23306J309), a late-stage biopharmaceutical company, today reported financial results for the Second Quarter ...

Celldex Therapeutics, Inc.: Celldex Announces Planned Transition of Chief Financial Officer

Celldex (NASDAQ:CLDX) announced today that Sam Martin, Senior Vice President and Chief Financial Officer, has informed the Company of his plans to retire ...